Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study

S Halvorsen, SP Johnsen, M Madsen… - … Journal-Quality of …, 2022 - academic.oup.com
Abstract Aims Using Scandinavian population-based registries, we assessed risk of
stroke/systemic embolism (SE) and bleeding with non-vitamin K antagonist oral …
被引用次数：12 相关文章

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study

S Halvorsen, SP Johnsen… - … journal. Quality of …, 2022 - pubmed.ncbi.nlm.nih.gov
Aims Using Scandinavian population-based registries, we assessed risk of stroke/systemic
embolism (SE) and bleeding with non-vitamin K antagonist oral anticoagulants compared …
[PDF] oup.com

[PDF][PDF] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study

S Halvorsen, SP Johnsen, M Madsen… - … Journal-Quality of …, 2022 - academic.oup.com
Abstract Aims Using Scandinavian population-based registries, we assessed risk of
stroke/systemic embolism (SE) and bleeding with non-vitamin K antagonist oral …
[HTML] nih.gov

[HTML][HTML] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study

S Halvorsen, SP Johnsen, M Madsen… - … Heart Journal. Quality …, 2022 - ncbi.nlm.nih.gov
Aims Using Scandinavian population-based registries, we assessed risk of stroke/systemic
embolism (SE) and bleeding with non-vitamin K antagonist oral anticoagulants compared …

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study

S Halvorsen, SP Johnsen, M Madsen… - … heart journal. Quality …, 2022 - research.regionh.dk
AIMS: Using Scandinavian population-based registries, we assessed risk of stroke/systemic
embolism (SE) and bleeding with non-vitamin K antagonist oral anticoagulants compared …

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study.

S Halvorsen, SP Johnsen, M Madsen… - … Heart journal. Quality …, 2022 - europepmc.org
Aims Using Scandinavian population-based registries, we assessed risk of stroke/systemic
embolism (SE) and bleeding with non-vitamin K antagonist oral anticoagulants compared …

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study

S Halvorsen, SP Johnsen, M Madsen, M Linder, G Sulo… - 2021 - bora.uib.no
Aims Using Scandinavian population-based registries, we assessed risk of stroke/systemic
embolism (SE) and bleeding with non-vitamin K antagonist oral anticoagulants compared …

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study

S Halvorsen, SP Johnsen, M Madsen… - European heart journal …, 2022 - vbn.aau.dk
AIMS: Using Scandinavian population-based registries, we assessed risk of stroke/systemic
embolism (SE) and bleeding with non-vitamin K antagonist oral anticoagulants compared …

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study

S Halvorsen, SP Johnsen, M Madsen, M Linder… - European Heart …, 2021 - duo.uio.no
Abstract Aims Using Scandinavian population-based registries, we assessed risk of
stroke/systemic embolism (SE) and bleeding with non-vitamin K antagonist oral …

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study

S Halvorsen, SP Johnsen, M Madsen, M Linder, G Sulo… - ikm.ku.dk
Aims Using Scandinavian population-based registries, we assessed risk of stroke/systemic
embolism (SE) and bleeding with non-vitamin K antagonist oral anticoagulants compared …